Cytotoxic T-cell-related gene expression signature predicts improved survival in muscle-invasive urothelial bladder cancer patients after radical cystectomy and adjuvant chemotherapy

JOURNAL ARTICLE published May 2020 in Journal for ImmunoTherapy of Cancer

Research funded by Deutsche Krebshilfe (110541)

Authors: Markus Eckstein | Pamela Strissel | Reiner Strick | Veronika Weyerer | Ralph Wirtz | Carolin Pfannstiel | Adrian Wullweber | Fabienne Lange | Philipp Erben | Robert Stoehr | Simone Bertz | Carol Imanuel Geppert | Nicole Fuhrich | Helge Taubert | Sven Wach | Johannes Breyer | Wolfgang Otto | Maximilian Burger | Christian Bolenz | Bastian Keck | Bernd Wullich | Arndt Hartmann | Danijel Sikic

Role of the Wnt-β-catenin signaling pathway in melanoma-mediated dendritic cell tolerization

JOURNAL ARTICLE published 2013 in Journal for ImmunoTherapy of Cancer

Authors: Alisha Holtzhausen | Kathy Evans | Brent A Hanks

199 Potent T cell costimulation mediated by a novel costimulatory antigen receptor (CoStAR) with dual CD28/CD40 signaling domains to improve adoptive cell therapies

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Martina Sykorova | Leyuan Bao | Cynthia Chauvin-Fleurence | Milena Kalaitsidou | Michelle Le Brocq | Robert Hawkins | Gray Kueberuwa | John Bridgeman | Rubén Alvarez-Rodríguez

Perspectives in immunotherapy: meeting report from the Immunotherapy Bridge (29-30 November, 2017, Naples, Italy)

JOURNAL ARTICLE published December 2018 in Journal for ImmunoTherapy of Cancer

Authors: Paolo A. Ascierto | James Brugarolas | Luigi Buonaguro | Lisa H. Butterfield | David Carbone | Bruno Daniele | Robert Ferris | Bernard A. Fox | Jérôme Galon | Cesare Gridelli | Howard L. Kaufman | Christopher A. Klebanoff | Ignacio Melero | Paul Nathan | Chrystal M. Paulos | Marco Ruella | Ryan Sullivan | Hassane Zarour | Igor Puzanov

A Phase I, open-label, dose escalation study of MGA271 in combination with ipilimumab in patients with B7-H3-expressing melanoma, squamous cell cancer of the head and neck or non-small cell lung cancer

JOURNAL ARTICLE published 2015 in Journal for ImmunoTherapy of Cancer

Authors: Walter Urba | Bartosz Chmielowski | Deryk Loo | Jan Baughman | Francine Chen | Paul Moore | Ezio Bonvini | James Vasselli | Jon Wigginton | Naiyer Rizvi

838 The role of microbiota in metastatic brain tumors

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Sarah Johnson | Golnaz Morad | Nadim Ajami | Jennifer Wargo | Matthew Wong | Matthew Lastrapes

Vaccination with pre-diagnostic tumor antigens but not established tumor antigens inhibits spontaneous tumorigenesis in TgMMTV-neu mice

JOURNAL ARTICLE published November 2013 in Journal for ImmunoTherapy of Cancer

Authors: Sasha E Stanton | Jianning Mao | John Ladd | Lauren Rastedder | Ekram Gad | Samir Hanash | Hailing Lu | Mary L Disis

Calcium ionophore pre-treatment induces type-1 polarized DCs with enhanced T cell stimulatory function and IL-12 production

JOURNAL ARTICLE published November 2013 in Journal for ImmunoTherapy of Cancer

Authors: Erik Berk | Shuwen Xu | Min Xu | Julia Terhune | Brian Czerniecki

Novel therapeutic and diagnostic antibodies against KIR3DL2, a unique tumor antigen overexpressed on subtypes of T cell lymphomas

JOURNAL ARTICLE published 2013 in Journal for ImmunoTherapy of Cancer

Authors: Anne Marie-Cardine | Nicolas Viaud | Arnaud Dujardin | Joly Rachel | Nathalie Granier | Laurent Gauthier | Cecile Bonnafous | Mathieu Blery | Carine Paturel | Armand Bensussan | Martine Bagot | Helene Sicard

Matched T cell repertoire analysis of peripheral blood and tumor-infiltrating lymphocytes (TILs) in early stage breast cancer (ESBC) patients (pts) treated with pre-operative cryoablation (cryo) and/or Ipilimumab (Ipi)

JOURNAL ARTICLE published December 2014 in Journal for ImmunoTherapy of Cancer

Authors: David B Page | Heather McArthur | Zhiwan Dong | Phillip Wong | Ryan Emerson | Zhenyu Mu | Chunjun Zhao | Christopher Comstock | Elizabeth Morris | Elizabeth Comen | Alan Kotin | Janice Sung | Edi Brogi | Monica Morrow | Stephen Solomon | Virgilio Sacchini | Majid Maybody | Deirdre Neville | Adi Diab | Padmanee Sharma | Harlan Robins | Sujata Patil | Jedd D Wolchok | Clifford Hudis | Larry Norton | James Allison | Jianda Yuan

Minimizing leukemia escape: implementing a dual anti-CD20- and CD19-scFv-based chimeric antigen receptor (CAR)

JOURNAL ARTICLE published December 2015 in Journal for ImmunoTherapy of Cancer

Authors: Dina Schneider | Ying Xiong | Andre Roy | Andrew Kaiser | Boro Dropulic | Rimas Orentas

836 Murine fecal microbiota transfer models colonize human microbes selectively and reveal transcriptional pathways associated with response to neoadjuvant checkpoint inhibitors

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Fyza Shaikh | Joell Gills | Fuad Mohammad | James White | Courtney Stevens | Hua Ding | Juan Fu | Ada Tam | Richard Blosser | Tatianna Larman | Jarushka Naidoo | Patrick Forde | Sudipto Ganguly | Franck Housseau | Drew Pardoll | Cynthia Sears

A "prime-pull" immunotherapy approach using a lentiviral vector and intratumoral TLR4 agonist redirects cytotoxic T cells

JOURNAL ARTICLE published December 2014 in Journal for ImmunoTherapy of Cancer

Authors: Tina C Albershardt | Andrea J Parsons | Patrick Flynn | Peter Berglund | Jan ter Meulen

348 Interleukin 2(IL-2) systems immunology modeling: machine learning for cancer immunotherapy

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Jennifer Bone | Newell Washburn | Jian Han | Miranda Steele | Pranav Murthy | Michael Lotze

Letter to the editor: radiomics analysis for predicting pembrolizumab response in patients with advanced rare cancers

JOURNAL ARTICLE published July 2021 in Journal for ImmunoTherapy of Cancer

Authors: Mateus Trinconi Cunha | Vinicius Jardim Carvalho | Rafael Maffei Loureiro | Carlos Eduardo Brantis-de-Carvalho | Murilo Bicudo Cintra | Gilberto de Castro Junior

IDH mutation-induced suppression of type-1 anti-glioma immune response

JOURNAL ARTICLE published December 2015 in Journal for ImmunoTherapy of Cancer

Authors: Gary Kohanbash | Shruti Shrivastav | Brian Ahn | Yafei Hou | Joseph Costello | Hideho Okada

Phase I study of alphaviral vector (AVX701) in colorectal cancer patients: comparison of immune responses in stage III and stage IV patients

JOURNAL ARTICLE published December 2015 in Journal for ImmunoTherapy of Cancer

Authors: Michael A Morse | Amy Hobeika | William Gwin | Takuya Osada | Jonathan Gelles | Christel Rushing | Donna Niedzwiecki | H Kim Lyerly

Combination radioimmunotherapy with adoptive NK transfer targets cancer stem cells in canine models of bone and soft tissue sarcoma

JOURNAL ARTICLE published December 2015 in Journal for ImmunoTherapy of Cancer

Authors: Robert Canter | Steven K Grossenbacher | Jiwon Sarah Park | Jaime Modiano | Erik Ames | Stephanie Mac | Arta M Monjazeb | Michael Kent | William Culp | Mingyi Chen | William Murphy

788 A novel T- lymphocyte binding aptamer assembled into a bispecifc compound for the treatment of solid tumors

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Irit Carmi Levy | Erez Lavi | Neta Zilony Hanin | Zohar Pode | Karin Mizrahi | Ronit Farhi | Anastasia Paz | Neria Reiss | Chen Shimoni | Vitaliy Buravenkov | Liron Levy-Efrati | Rotem Haimovich | Ohad Glaich | Itay Liron | Hadas Aharoni Zazrin | Ido Bachelet | Raanan Berger | Guy Neev

161 Anti-myeloid poly-pharmacy combined with FGFR4-targeted chimeric antigen receptors (CARs) effectively treats orthotopic rhabdomyosarcoma, modeling CAR effectiveness for solid tumors

JOURNAL ARTICLE published November 2021 in Journal for ImmunoTherapy of Cancer

Authors: Peter Sullivan | Rajesh Kumar | Wei Li | Lingyang Wang | Yue Zhang | Adam Cheuk | Javed Khan | Dimiter Dimitrov | Rimas Orentas